Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Wegovy, which was initially marketed at more than $1,300 per month, is now offered by Novo Nordisk directly to consumers for about $499 per month
Triplehormone-receptor agonist retatrutide for obesity A phase 2 trial
Additional information Batch Tested Reta (GLP3) with verifiable Certificate of Analysis Overall rating* * Rating is required Product Quality* * Rating is required Dispatch Speed* * Rating is required Overall Experience* * Rating is required * Answer is required Email * Email is required
otherwise, skip it and resume your regular schedule
Updated February 2026 Mounjaro vs Ozempic: Which Is Better for Weight Loss and Diabetes
One is due to slowed gastric emptying
US$ 28.56
US$ 20.07
US$ 20.83
US$ 20.14
US$ 25.20
US$ 21.67
US$ 21.72
US$ 22.04
US$ 24.58
